230 related articles for article (PubMed ID: 26448102)
1. Class I and Class II Lanthipeptides Produced by Bacillus spp.
Barbosa J; Caetano T; Mendo S
J Nat Prod; 2015 Nov; 78(11):2850-66. PubMed ID: 26448102
[TBL] [Abstract][Full Text] [Related]
2. Lantibiotics: promising candidates for future applications in health care.
Dischinger J; Basi Chipalu S; Bierbaum G
Int J Med Microbiol; 2014 Jan; 304(1):51-62. PubMed ID: 24210177
[TBL] [Abstract][Full Text] [Related]
3. Improving the attrition rate of Lanthipeptide discovery for commercial applications.
Geng M; Smith L
Expert Opin Drug Discov; 2018 Feb; 13(2):155-167. PubMed ID: 29195488
[TBL] [Abstract][Full Text] [Related]
4. Cacaoidin, First Member of the New Lanthidin RiPP Family.
Ortiz-López FJ; Carretero-Molina D; Sánchez-Hidalgo M; Martín J; González I; Román-Hurtado F; de la Cruz M; García-Fernández S; Reyes F; Deisinger JP; Müller A; Schneider T; Genilloud O
Angew Chem Int Ed Engl; 2020 Jul; 59(31):12654-12658. PubMed ID: 32407589
[TBL] [Abstract][Full Text] [Related]
5. Strategies for the isolation and characterization of antibacterial lantibiotics.
Jabes D; Donadio S
Methods Mol Biol; 2010; 618():31-45. PubMed ID: 20094856
[TBL] [Abstract][Full Text] [Related]
6. Lantibiotics, class I bacteriocins from the genus Bacillus.
Lee H; Kim HY
J Microbiol Biotechnol; 2011 Mar; 21(3):229-35. PubMed ID: 21464591
[TBL] [Abstract][Full Text] [Related]
7. Screening, purification and characterization of thermostable, protease resistant Bacteriocin active against methicillin resistant Staphylococcus aureus (MRSA).
Ansari A; Zohra RR; Tarar OM; Qader SAU; Aman A
BMC Microbiol; 2018 Nov; 18(1):192. PubMed ID: 30466388
[TBL] [Abstract][Full Text] [Related]
8. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
Escano J; Ravichandran A; Salamat B; Smith L
Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
[TBL] [Abstract][Full Text] [Related]
9. Diversity and applications of Bacillus bacteriocins.
Abriouel H; Franz CM; Ben Omar N; Gálvez A
FEMS Microbiol Rev; 2011 Jan; 35(1):201-32. PubMed ID: 20695901
[TBL] [Abstract][Full Text] [Related]
10. Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic.
Huo L; van der Donk WA
J Am Chem Soc; 2016 Apr; 138(16):5254-7. PubMed ID: 27074593
[TBL] [Abstract][Full Text] [Related]
11. Formicin - a novel broad-spectrum two-component lantibiotic produced by Bacillus paralicheniformis APC 1576.
Collins FWJ; O'Connor PM; O'Sullivan O; Rea MC; Hill C; Ross RP
Microbiology (Reading); 2016 Sep; 162(9):1662-1671. PubMed ID: 27450592
[TBL] [Abstract][Full Text] [Related]
12. Rapid Discovery of Glycocins through Pathway Refactoring in Escherichia coli.
Ren H; Biswas S; Ho S; van der Donk WA; Zhao H
ACS Chem Biol; 2018 Oct; 13(10):2966-2972. PubMed ID: 30183259
[TBL] [Abstract][Full Text] [Related]
13. Class II antimicrobial peptides from lactic acid bacteria.
Nes IF; Holo H
Biopolymers; 2000; 55(1):50-61. PubMed ID: 10931441
[TBL] [Abstract][Full Text] [Related]
14. Bacteriocin production by Bifidobacterium spp. A review.
Martinez FA; Balciunas EM; Converti A; Cotter PD; de Souza Oliveira RP
Biotechnol Adv; 2013; 31(4):482-8. PubMed ID: 23384878
[TBL] [Abstract][Full Text] [Related]
15. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
[TBL] [Abstract][Full Text] [Related]
16. Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity.
Wang J; Zhang L; Teng K; Sun S; Sun Z; Zhong J
Appl Environ Microbiol; 2014 Apr; 80(8):2633-43. PubMed ID: 24532070
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.
Yang X; Yousef AE
World J Microbiol Biotechnol; 2018 Mar; 34(4):57. PubMed ID: 29594558
[TBL] [Abstract][Full Text] [Related]
18. Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production.
Ongey EL; Neubauer P
Microb Cell Fact; 2016 Jun; 15():97. PubMed ID: 27267232
[TBL] [Abstract][Full Text] [Related]
19. Bacteroidetes can be a rich source of novel lanthipeptides: The case study of Pedobacter lusitanus.
Caetano T; van der Donk W; Mendo S
Microbiol Res; 2020 May; 235():126441. PubMed ID: 32109689
[TBL] [Abstract][Full Text] [Related]
20. The lanthipeptides of Bacillus methylotrophicus and their association with genomic islands.
Dias L; Caetano T; Pinheiro M; Mendo S
Syst Appl Microbiol; 2015 Dec; 38(8):525-33. PubMed ID: 26559891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
